HK1101346A1 - Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient - Google Patents

Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient

Info

Publication number
HK1101346A1
HK1101346A1 HK07106112.3A HK07106112A HK1101346A1 HK 1101346 A1 HK1101346 A1 HK 1101346A1 HK 07106112 A HK07106112 A HK 07106112A HK 1101346 A1 HK1101346 A1 HK 1101346A1
Authority
HK
Hong Kong
Prior art keywords
low
active ingredient
dry powder
pharmaceutical formulations
powder inhalers
Prior art date
Application number
HK07106112.3A
Other languages
English (en)
Inventor
Roberto Bilzi
Angela Armanni
Roberto Rastelli
Daniela Cocconi
Rossella Musa
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34962706&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1101346(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of HK1101346A1 publication Critical patent/HK1101346A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK07106112.3A 2004-03-17 2007-06-07 Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient HK1101346A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04006430 2004-03-17
PCT/EP2005/002789 WO2005089717A1 (en) 2004-03-17 2005-03-16 Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient

Publications (1)

Publication Number Publication Date
HK1101346A1 true HK1101346A1 (en) 2007-10-18

Family

ID=34962706

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07106112.3A HK1101346A1 (en) 2004-03-17 2007-06-07 Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient

Country Status (20)

Country Link
US (1) US8153104B2 (xx)
EP (1) EP1729728B1 (xx)
KR (1) KR20060130216A (xx)
CN (1) CN1942172B (xx)
AR (1) AR049010A1 (xx)
AU (1) AU2005224008B2 (xx)
BR (1) BRPI0508170A (xx)
CA (1) CA2560226C (xx)
ES (1) ES2566618T3 (xx)
HK (1) HK1101346A1 (xx)
JO (1) JO3102B1 (xx)
MA (1) MA28514B1 (xx)
MX (1) MXPA06010593A (xx)
NO (1) NO342481B1 (xx)
NZ (1) NZ549870A (xx)
PE (1) PE20060716A1 (xx)
RU (1) RU2371171C2 (xx)
TN (1) TNSN06277A1 (xx)
WO (1) WO2005089717A1 (xx)
ZA (1) ZA200607700B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1944018A1 (en) * 2007-01-10 2008-07-16 CHIESI FARMACEUTICI S.p.A. Micronised particles of low-dosage strength active agents for powder formulations for inhalation
JP2010519195A (ja) * 2007-02-19 2010-06-03 シプラ・リミテッド 薬学的組成物
EP2191821A1 (en) 2008-11-26 2010-06-02 CHIESI FARMACEUTICI S.p.A. Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation
TWI491416B (zh) * 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
WO2011031564A2 (en) * 2009-08-27 2011-03-17 Stc.Unm Methods and systems for dosing and coating inhalation powders onto carrier particles
EP2360147A1 (en) * 2010-02-22 2011-08-24 CHIESI FARMACEUTICI S.p.A. Process for preparing crystalline particles of a salt of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-quinolinone (carmoterol)
TR201811349T4 (tr) * 2010-04-01 2018-09-21 Chiesi Farm Spa İnhalasyon i̇çi̇n kuru toz taşiyici parti̇külleri̇n hazirlanmasi i̇çi̇n proses.
DE102011102614A1 (de) * 2011-05-27 2012-11-29 Roland Nied Verfahren zum Betrieb einer Strahlmühle sowie Strahlmühle
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
ES2683254T3 (es) * 2012-01-25 2018-09-25 Chiesi Farmaceutici S.P.A. Formulación en polvo seca que comprende un corticoesteroide y un beta-adrenérgico para administración por inhalación
NZ722952A (en) * 2012-02-28 2018-12-21 Iceutica Holdings Inc Inhalable pharmaceutical compositions
EP2836204B1 (en) 2012-04-13 2020-07-08 GlaxoSmithKline Intellectual Property Development Limited Aggregate particles
JP5087182B1 (ja) * 2012-06-13 2012-11-28 クリニプロ株式会社 吸入用パウダーの製造方法
SG11201507466XA (en) 2013-03-13 2015-10-29 Forest Lab Holdings Ltd Micronized pharmaceutical compositions
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
ES2867552T3 (es) 2013-07-11 2021-10-20 Chiesi Farm Spa Formulación en polvo seco que comprende un anticolinérgico, un corticosteroide y un betaadrenérgico para administración por inhalación
US9427376B2 (en) * 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
CN104800192A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入粉雾剂及制备方法
MY181647A (en) 2014-09-09 2020-12-30 Vectura Ltd Formulation comprising glycopyrrolate, method and apparatus
US10583085B2 (en) * 2017-05-17 2020-03-10 Chiesi Farmaceutici S.P.A. Carrier particles for dry powder formulations for inhalation
CN109200034A (zh) * 2017-06-30 2019-01-15 正大天晴药业集团股份有限公司 一种可吸入干粉形式的组合物及其制备方法
GB201911517D0 (en) * 2019-08-12 2019-09-25 Verona Pharma Plc Pharmaceutical composition
IL293079A (en) * 2019-12-16 2022-07-01 Seagen Inc High-performance liquid chromatography quantification of excipients
WO2021236570A1 (en) * 2020-05-18 2021-11-25 Anovent Pharmaceutical (U.S.), Llc Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59100388D1 (de) 1990-01-29 1993-10-28 Ciba Geigy Verfahren und Vorrichtung zur Dosierung eines feinkörnigen Pulvers.
US6673335B1 (en) * 1992-07-08 2004-01-06 Nektar Therapeutics Compositions and methods for the pulmonary delivery of aerosolized medicaments
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
IT1309592B1 (it) * 1999-03-05 2002-01-24 Chiesi Farma Spa Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
JP2004515467A (ja) * 2000-08-07 2004-05-27 ネクター セラピューティックス 吸入可能な、噴霧乾燥した、最少の凝集物を有する４−ヘリックスバンドルタンパク質粉末
US6587025B2 (en) * 2001-01-31 2003-07-01 Vishay Dale Electronics, Inc. Side-by-side coil inductor
WO2005004846A1 (en) * 2003-07-11 2005-01-20 Glaxo Group Limited Pharmaceutical formulations
EP2080508A1 (en) * 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Dry powder formulation comprising an anticholinergic drug

Also Published As

Publication number Publication date
NO20064161L (no) 2006-10-17
US20070202053A1 (en) 2007-08-30
CN1942172A (zh) 2007-04-04
AU2005224008B2 (en) 2010-09-16
WO2005089717A1 (en) 2005-09-29
CA2560226A1 (en) 2005-09-29
EP1729728A1 (en) 2006-12-13
AR049010A1 (es) 2006-06-21
RU2006133038A (ru) 2008-03-20
AU2005224008A1 (en) 2005-09-29
NZ549870A (en) 2010-05-28
KR20060130216A (ko) 2006-12-18
PE20060716A1 (es) 2006-07-25
NO342481B1 (no) 2018-05-28
TNSN06277A1 (en) 2007-12-03
CN1942172B (zh) 2010-10-06
US8153104B2 (en) 2012-04-10
EP1729728B1 (en) 2016-03-16
MA28514B1 (fr) 2007-04-03
MXPA06010593A (es) 2007-02-16
ES2566618T3 (es) 2016-04-14
ZA200607700B (en) 2008-05-28
CA2560226C (en) 2013-07-23
JO3102B1 (ar) 2017-09-20
BRPI0508170A (pt) 2007-08-07
RU2371171C2 (ru) 2009-10-27

Similar Documents

Publication Publication Date Title
HK1101346A1 (en) Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
HUS1800032I1 (hu) Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
EP1635762A4 (en) LOW DOSE INHALABLE PHARMACEUTICAL POWDERS
GB2441053B (en) Drug capsules for dry powder inhalers
ZA200808965B (en) Pharmaceutical solution formulations for pressurised metered dose inhalers
TWI366460B (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
IL221770A (en) Edamantyl acetamide derivatives, the pharmaceutical composition containing them and its use in the preparation of a drug
HUP0300593A3 (en) Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
IL177120A0 (en) Formulations for poorly soluble drugs
BRPI0507225A2 (pt) formulações estáveis de solução farmacêutica para inaladores pressurizados de dose medida
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
HK1126671A1 (en) Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
IL190698A0 (en) Nanoparticulate active ingredient formulations
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
HK1116337A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
HK1098962A1 (en) Antimycobacterial pharmaceutical composition comprising an antitubercular drug
HK1103280A1 (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
PL2150267T3 (pl) Farmaceutyczna i/lub kosmetyczna kompozycja zawierająca składnik aktywny aktywujący cytochrom c
ZA200606577B (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
HK1098954A1 (en) Solid pharmaceutical preparation containing sparingly water-soluble drug